IVUSE has revolutionized Atlanta's IV therapy landscape with unparalleled customer growth and the introduction of cutting-edge wellness and weight loss treatments, reaffirming its dedication to health innovation and personalized care.
Read MoreThe Food and Drug Administration approves CAR T-Cell therapy Carvykti® as a second-line treatment and the CAR T-Cell therapy Abecma® as a third-line treatment for adult patients with multiple myeloma.
Read MoreDuring Limb Loss and Limb Difference Awareness Month, Ottobock North America reaffirms its commitment to supporting the limb loss and limb difference community not just during April, but every day of the year.
Read MoreFollowing favorable FDA feedback for the treatment of liver disease, the company is preparing further pre-IND meetings with the FDA for the treatment of atherosclerosis and familial hypercholesterolemia
Read MoreDuring Limb Loss and Limb Difference Awareness Month, Ottobock North America reaffirms its commitment to supporting the limb loss and limb difference community not just during April, but every day of the year.
Read MoreThis additional funding comes at the heels of Selux announcing their third FDA 510(k) clearance on their direct from Positive Blood Culture Separator, making them the only single-platform technology capable of delivering rapid AST results for both positive blood culture and isolated colonies.
Read MoreUnify Medical, Inc., a privately held, smart surgical visualization technology company, announced the appointment of experienced Air Force surgeon Dr. Todd Rasmussen as Special Consultant for its increasing medical military initiatives.
Read MoreGeneral Catalyst leads funding round joined by .406 Ventures, Valtruis, Mass General Brigham Ventures, and Hopelab Foundation to bolster insurance-based mental health program availability in new markets
Read MoreDropSafe® Sicura™ is the first and only fully passive safety needle in North America. Sicura™ designed to eliminate needlestick injuries, providing a safe injection experience, and is distributed by HTL-Strefa Inc., an MTD company.
Read MoreDr. Anthony P. Urbanek, D.D.S., M.S., M.D., one of the country’s most highly regarded Oral and Maxillofacial Surgeons and pioneer in the treatment of Temporomandibular Disorders, has chosen the In Hand Dental app for the purposes of monitoring and treating his patients.
Read More